The incidence and patient outcomes of ABSSSI by iclaprim MIC values in the phase 3 REVIVE trials for treatment of acute bacterial skin and skin structure infections
Year: 2019
Type: article
Source: Journal of Medical Microbiology
DOI: 10.1099/jmm.0.000989
Authors: David B. Huang, Cedric Charrier, Chloé Le Bras, Stephen Hawser, Stephanie Noviello
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2943808544